Jeisys Medical Surpasses 300 Cumulative Unit Sales in Brazil Within 10 Months of Subsidiary Launch
in the world's third-largest medical aesthetics market.

SEOUL, South Korea, July 27, 2026 — Jeisys Medical, a global leader in energy-based medical aesthetic devices, today announced that its Brazilian subsidiary, Jeisys Medical Brasil Ltda, surpassed 300 cumulative unit sales of its core platforms—LinearZ, Density, and Potenza—just 10 months after its official establishment.
Reaching this sales milestone in Brazil, recognized as the world's third-largest medical aesthetics market, highlights Jeisys Medical’s successful market entry against established international competitors. The company attributes this rapid adoption to its physician-centric academic marketing and sustained customer engagement strategies.
To strengthen connections with local healthcare professionals, Jeisys Medical hosted 'TEA Brasil' on June 16. The hybrid event brought together over 800 live and virtual medical practitioners, generating more than 60 high-value business leads for prospective acquisitions and cross-selling across its product portfolio.
Leveraging its strategic tagline, "Because Excellence is a Conscious Choice," Jeisys Medical has reinforced its position as a high-technology, safety-first medical aesthetics provider. The brand's local visibility has further expanded through feature coverage in top-tier Brazilian media outlets, including Vogue, Harper's Bazaar, and Marie Claire.
"Surpassing 300 unit sales within just 10 months of launching our Brazilian subsidiary is a testament to our localized market strategy and strong brand positioning," said a spokesperson for Jeisys Medical. "By securing top-tier local talent and maintaining academic-driven engagement with physicians, we have laid a solid foundation. We will continue to expand our clinical education, technical services, and product line to consolidate our leadership in the Brazilian market."